Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

María Contel

18PUBLICATIONS
23CO-AUTHORS
Metal organic frameworksGene and molecular therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

Sort by Publication Date:
|May 18, 2026
Cytotoxicity and immunogenic cell death studies of water-soluble tetrahedral Ga(iii) or Fe(iii) coordination cages containing a Au(i) anticancer drug as guest.

|Sep 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model".

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

|May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound.

Nazia Nayeem, Sami Sauma, Afruja Ahad

|Jan 29, 2024
Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers.

Afruja Ahad, Fatima Aftab, Alexa Michel

|Jan 17, 2024
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model".

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

|Dec 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model.

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

Pageof 3

Frequent Collaborators

6 joint publications

Nazia Nayeem

5 joint publications

Afruja Ahad

4 joint publications

Rein V Ulijn

4 joint publications

Jason S Lewis

3 joint publications

Hiwa K Saeed

3 joint publications

Ignacio E León

3 joint publications

Michelle C Neary

2 joint publications

Jiye Son

2 joint publications

Lucía Otero

2 joint publications

Dhwanit Dave

Frequent Collaborators

6 joint publications

Nazia Nayeem

5 joint publications

Afruja Ahad

4 joint publications

Rein V Ulijn

4 joint publications

Jason S Lewis